Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease.
about
Erythropoietin: new directions for the nervous systemShedding new light on neurodegenerative diseases through the mammalian target of rapamycinWhat's New in Traumatic Brain Injury: Update on Tracking, Monitoring and TreatmentAltered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis.Oxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discoveryNovel avenues of drug discovery and biomarkers for diabetes mellitus.Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead array.Translating cell survival and cell longevity into treatment strategies with SIRT1AKT/GSK3 signaling pathway and schizophreniaPrevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL.Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injuryNew avenues of exploration for erythropoietin.Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathwaysThe pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection.Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicityEmploying new cellular therapeutic targets for Alzheimer's disease: a change for the better?Vital elements of the Wnt-Frizzled signaling pathway in the nervous system.Winding through the WNT pathway during cellular development and demiseDriving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide.Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitusTriple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.The Wnt signaling pathway: aging gracefully as a protectionist?Erythropoietin: elucidating new cellular targets that broaden therapeutic strategiesMechanistic insights into diabetes mellitus and oxidative stressThe Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury."Sly as a FOXO": new paths with Forkhead signaling in the brainErythropoietin and oxidative stress.A "FOXO" in sight: targeting Foxo proteins from conception to cancer.The forkhead transcription factor FOXO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3Therapeutic promise and principles: metabotropic glutamate receptorsThe vitamin nicotinamide: translating nutrition into clinical care.Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model.
P2860
Q26828425-AA5CF9B1-F103-43D0-A0FD-8722EAEA6A8EQ27015640-52EC772E-6EFB-467C-BFB4-9CE5F5A4A9FEQ30959630-371FEC8A-99AE-4130-8905-83CFD233103AQ31146509-032D430E-48C3-4E12-9B4B-85BF0B9652C4Q33604706-AB74A2DE-0E41-4D80-8AB0-7A21E5E50804Q33682262-88C59EBB-8BC2-4FF1-8F12-7090DA4D8963Q33717008-DF6D03D3-B496-47F5-B1AE-9314CD31C21EQ33749358-BF73A622-0B67-4DE9-A231-339DA4956D10Q34552287-E53DF4FC-C3B2-4454-9996-0F3D2435A874Q35143061-79DDA38B-D8E5-42B2-AC39-40197CE3CDD1Q35157985-9D566AB7-343E-4361-831A-0555043039AAQ35161490-05E397D6-D274-481D-9597-FC3C713F2C67Q35660308-6C1ABC16-BAD9-4812-91D4-E0D8EA26F24AQ35832061-90C95B8D-3B14-4AF2-AB21-FFAC2B52F5C3Q35947388-BE795E1D-E76A-4DED-9429-270E751A9C29Q35971676-F67814CC-C7CB-4B24-A203-82FC63571038Q35999785-50DE5961-47B1-43D6-9175-6CB37246D68AQ36002822-98E00A6D-7B52-4E7F-88D6-063CB2AE92ABQ36002849-28ED1B39-0095-4E6C-8CE7-E6BC72F29AC7Q36002875-A511CA2E-D19C-4ACD-83B7-BD7F6D6E596AQ36002879-88C2430B-2D75-4EA2-93B1-7BB8C863921CQ36266206-807FDF61-FA86-4975-9FAA-8267E1A65583Q36266255-23E6D6EB-6BE5-47ED-BBDE-218615692CADQ36305544-84235CC7-C9CC-4304-8B56-78BF26AAF119Q36352348-2630FB47-76B7-40D4-A7C7-4247E64C8ED6Q36447198-55730A75-EAEE-4ED4-9028-A7DC84635D42Q36663152-E729AF41-1EC7-4E66-969B-FA88EEBFC3E4Q36727444-FED043C7-177D-45C1-9338-4F4AF40CD6F1Q36728844-BD38C735-636E-4367-A5A3-61458281E810Q36740470-58DC5F4F-1646-4A04-BA79-506B5228FE9AQ36748171-3A7F05B1-E0D8-401E-A2E9-B51B5C586D9AQ36836455-566ACA04-DFD8-4D2B-9E06-00B2644EA543Q36944469-8D9F975A-B8E8-41C4-A90B-E8FC8D3B92B3Q36944477-F970533F-12A5-4B34-A7BB-78CF6651D764Q37153195-E528466B-5056-430B-92CA-00B7C961B3DEQ37156425-FF65BE86-75FA-4EB9-8CF1-32E38DC1F26BQ37340240-F7771BD3-47B9-4574-8E26-0F6AA55C3C0FQ37374047-816F1C6D-875F-4BD4-8BAD-B13F638E2A18Q40397067-EA024417-2ED8-45F9-890D-139000723F87
P2860
Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Insights into oxidative stress ...... targets for Alzheimer disease.
@ast
Insights into oxidative stress ...... targets for Alzheimer disease.
@en
type
label
Insights into oxidative stress ...... targets for Alzheimer disease.
@ast
Insights into oxidative stress ...... targets for Alzheimer disease.
@en
prefLabel
Insights into oxidative stress ...... targets for Alzheimer disease.
@ast
Insights into oxidative stress ...... targets for Alzheimer disease.
@en
P1476
Insights into oxidative stress ...... targets for Alzheimer disease.
@en
P2093
Kenneth Maiese
Zhao Zhong Chong
P304
P577
2004-01-01T00:00:00Z